Cargando…
Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation
Hepatitis C recurrence continues to present a major challenge in liver transplantation (LT). Approximately 10% of hepatitis C virus (HCV)-positive recipients will develop fibrosing cholestatic hepatitis (FCH) after LT. FCH is clinically characterized as marked jaundice with cholestatic hepatic dysfu...
Autores principales: | Hori, Tomohide, Onishi, Yasuharu, Kamei, Hideya, Kurata, Nobuhiko, Ishigami, Masatoshi, Ishizu, Yoji, Ogura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049551/ https://www.ncbi.nlm.nih.gov/pubmed/27708510 http://dx.doi.org/10.20524/aog.2016.0069 |
Ejemplares similares
-
Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma
por: Hori, Tomohide, et al.
Publicado: (2016) -
Donor Selection and Prophylactic Strategy for Venous Thromboembolic Events in Living Donors of Liver Transplantation Based on Results of Thrombophilia Screening Tests
por: Kamei, Hideya, et al.
Publicado: (2017) -
Development of extensive inferior vena cava thrombosis due to the ligation of a large mesenteric-caval shunt during liver transplantation: A case report
por: Kamei, Hideya, et al.
Publicado: (2016) -
Successful adult-to-adult living donor liver transplantation using liver allograft after the resection of hemangioma: A suggestive case for a further expansion of living donor pool
por: Onishi, Yasuharu, et al.
Publicado: (2015) -
Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
por: Nomura, Aya, et al.
Publicado: (2020)